BIO

Bio Rad
NYSE

Real-time Quotes | Nasdaq Last Sale

400.50
-8.57
-2.10%
After Hours: 400.50 0 0.00% 16:12 02/21 EST
OPEN
406.69
PREV CLOSE
409.07
HIGH
406.69
LOW
397.04
VOLUME
154.58K
TURNOVER
--
52 WEEK HIGH
413.02
52 WEEK LOW
268.96
MARKET CAP
11.99B
P/E (TTM)
6.88
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BIO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BIO stock price target is 443.75 with a high estimate of 450.00 and a low estimate of 435.00.

EPS

BIO News

More
  • The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion
  • Benzinga · 1d ago
  • The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study
  • Benzinga · 2d ago
  • The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA
  • Benzinga · 3d ago
  • Edited Transcript of BIO earnings conference call or presentation 13-Feb-20 10:00pm GMT
  • Thomson Reuters StreetEvents · 4d ago

Industry

Medical Equipment, Supplies & Distribution
-0.81%
Healthcare Equipment & Supplies
-0.65%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About BIO

Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory instruments. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.
More

Webull offers kinds of Bio-Rad Laboratories, Inc. stock information, including NYSE:BIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIO stock news, and many more online research tools to help you make informed decisions.